Brief: EPS Creative Health Technology Enters MoU For 16.23% Equity Interest In China Genetic
03/02/2026 10:29
Feb 3 (Reuters) - EPS Creative Health Technology Group Ltd 3860.HK: ENTERS MOU WITH HONESTAR MEDICAL FOR 16.23% EQUITY INTEREST IN CHINA GENETIC SHALL NEGOTIATE THE TOTAL CONSIDERATION FOR DEAL BETWEEN HK$40 MILLION-HK$45 MILLION Further company coverage: 3860.HK ((Reuters.Briefs@thomsonreuters.com;))
Recent news on EPS Creative Health Technology
See all newsBrief: EPS Creative Health Technology Expects HK$8-12 Million Increase In HY Loss After Taxation For
Brief: EPS Creative Health Technology Says Controlling Shareholder To Dispose Up To 130 Mln Shares
Brief: EPS Creative Health Technology Terminates Proposed Acquisition With No Liability
Brief: EPS Creative Health Technology To Acquire 16.23% Of China Genetic
Brief: EPS Creative Health Technology Enters MoU For 16.23% Equity Interest In China Genetic